NORMA LIRA: Open Payments
NPI 1225807209 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,474 in 53 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,087 · 2025 $3,474
Food & beverage: $2,294Travel & lodging: $1,127Education: $54
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 25 | $1,996 |
| SI-BONE, INC. | 3 | $340 |
| Abbott Laboratories | 6 | $289 |
| MML US, Inc. | 4 | $220 |
| Boston Scientific Corporation | 3 | $211 |
| ABIOMED | 1 | $119 |
| Amarin Pharma, Inc. | 1 | $113 |
| Valinor Pharma, LLC | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| SPR Therapeutics, Inc | 1 | $28 |
Products named: SYNCHROMEDII, PROCLAIM, ReActiv8, AMS 700, Vascepa, INCEPTIV, Intracept, MOVANTIK.
Industry payments across TX — which companies pay providers there.
